Humalog (Eli Lily) en es it fr

Humalog (Eli Lily) Brand names, Humalog (Eli Lily) Analogs

Humalog (Eli Lily) Brand Names Mixture

  • No information avaliable

Humalog (Eli Lily) Chemical_Formula

C257H387N65O76S6

Humalog (Eli Lily) RX_link

http://www.drugs.com/cons/Insulin_Lispro.html

Humalog (Eli Lily) fda sheet

Humalog (Eli Lily) msds (material safety sheet)

Humalog (Eli Lily) Synthesis Reference

No information avaliable

Humalog (Eli Lily) Molecular Weight

5808

Humalog (Eli Lily) Melting Point

81 oC (Khachidze, D.G. et al., J. Biol. Phys. Chem. 1:64-67 (2001))

Humalog (Eli Lily) H2O Solubility

No information avaliable

Humalog (Eli Lily) State

Liquid

Humalog (Eli Lily) LogP

0.218

Humalog (Eli Lily) Dosage Forms

Solution (Subcutaneous Injection and Infusion, IV Administration); Suspension

Humalog (Eli Lily) Indication

For treatment of diabetes (type I and II)

Humalog (Eli Lily) Pharmacology

Used in the treatment of type I and type II diabetes. The primary activity of insulin is the regulation of glucose metabolism. In muscle and other tissues (except the brain), insulin causes rapid transport of glucose and amino acids intracellularly. It also promotes anabolism, and inhibits protein catabolism. In the liver, insulin promotes the uptake and storage of glucose in the form of glycogen, inhibits gluconeogenesis, and promotes the conversion of excess glucose into fat.

Humalog (Eli Lily) Absorption

No information avaliable

Humalog (Eli Lily) side effects and Toxicity

No information avaliable

Humalog (Eli Lily) Patient Information

No information avaliable

Humalog (Eli Lily) Organisms Affected

Humans and other mammals